2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC4895
  



  

  
Submitter : 
  

  
Mr. Felix Spitelle
  

  
Date & Time: 
  

  
12/28/2006 09:12:45
  



  

  
Organization : 
  

  
Knights of Columbus
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I would like to register my firm opposition to the FDA's plan to use aborted fetal cell line products in the development of vaccines. It is an affront to the dignity of the human person to use genetical material gathered involuntarily from the donor to treat disease. I strongly urge the FDA to seriously consider its decision and disregard this option entirely. Please do the right thing!